Cargando…
Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert–Eaton myasthenic syndrome: two case reports
INTRODUCTION: Lambert–Eaton myasthenic syndrome is a rare autoimmune disorder of neuromuscular transmission due to the presence of antibodies to presynaptic P/Q-type voltage-gated calcium channels. The gold standard of therapy is the potassium channel blocker 3,4-diaminopyridine. To the best of our...
Autores principales: | Schneider, Ilka, Kornhuber, Malte E, Hanisch, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376498/ https://www.ncbi.nlm.nih.gov/pubmed/25885033 http://dx.doi.org/10.1186/s13256-015-0524-9 |
Ejemplares similares
-
Lung adenocarcinoma with Lambert–Eaton myasthenic syndrome indicated by voltage-gated calcium channel: a case report
por: Arai, Hiromasa, et al.
Publicado: (2012) -
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Lambert-Eaton Myasthenic Syndrome in Lung Cancer
por: Wang, Yongbin, et al.
Publicado: (2022) -
Lowering the cutoff value for increment increases the sensitivity for the diagnosis of Lambert‐Eaton myasthenic syndrome
por: Lipka, Alexander F., et al.
Publicado: (2020) -
Lambert-Eaton Myasthenic Syndrome; Pathogenesis, Diagnosis, and Therapy
por: Gilhus, Nils Erik
Publicado: (2011)